Literature DB >> 25081683

Down-regulation of FRα inhibits proliferation and promotes apoptosis of cervical cancer cells in vitro.

Li-Xia Bai1, Ling Ding, Shi-Wen Jiang, Hui-Jie Kang, Chen-Fei Gao, Chen Chen, Qin Zhou, Jin-Tao Wang.   

Abstract

Folate receptor alpha (FRα) mediates folate uptake by endocytosis, and while folate is essential to DNA methylation and synthesis and may have an important role in proliferating cells. FRα is known to be expressed in rapidly proliferating cells, including many cancer cell lines, but there has been no systematic assessment of expression in cervical cancer cell lines. The aim of the present study was to evaluate the effects of FRα on proliferation and apoptosis of cervical cells and correlation mechanism. In this study, we investigated the biological function of FRα in Hela cells using RNA interference. Cell proliferation was evaluated by Cell Counting Kit-8 (CCK8) assay, while cell cycling and apoptosis were assessed by flow cytometry, mRNA levels by real time- PCR and protein levels of FRα, c-Fos and c-Jun by Western blotting. The results revealed that FRα was highly expressed in Hela cells and its silencing with a small interfering RNA (siRNA) inhibited cell proliferation and induced cell apoptosis, arresting the cell cycle in G0/G1 stages while decreasing the proportion in S and G2/M stages, and suppressed the expression levels of c-Fos and c-Jun. In conclusion, the results of this study indicated that FRα down-regulation might be capable of suppressing cervical cancer cell proliferation and promoting apoptosis. It suggested that FRα might be a novel therapeutic target for cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25081683     DOI: 10.7314/apjcp.2014.15.14.5667

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

Review 1.  Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible?

Authors:  R N Sharan; S Thangminlal Vaiphei; Saibadaiahun Nongrum; Joshua Keppen; Mandahakani Ksoo
Journal:  Cell Oncol (Dordr)       Date:  2015-09-18       Impact factor: 6.730

2.  PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.

Authors:  Zheng Bo Hu; Xiao Hong Liao; Zun Ying Xu; Xiao Yang; Chao Dong; An Min Jin; Hai Lu
Journal:  Cancer Med       Date:  2015-12-02       Impact factor: 4.452

Review 3.  Targeted Gene Delivery Therapies for Cervical Cancer.

Authors:  Ángela Áyen; Yaiza Jiménez Martínez; Houria Boulaiz
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

4.  Predict the Progression of Cervical Intraepithelial Neoplasia by a Novel Marker Folate Combine with FRα, p16 and Ki-67.

Authors:  Tingting Liu; Mengjie Chen; Xueqin Li; He Wang
Journal:  Int J Gen Med       Date:  2022-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.